<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!-- saved from url=(0052)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/ -->
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3091944/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Effect of Single-dose Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="./PMC3091944_files/jig.min.css"><script type="text/javascript" src="./PMC3091944_files/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Clinical pharmacology and therapeutics"><meta name="citation_title" content="Effect of Single-dose Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers"><meta name="citation_authors" content="A Frymoyer, S Shugarts, M Browne, AHB Wu, L Frassetto, LZ Benet"><meta name="citation_date" content="October 2010"><meta name="citation_issue" content="4"><meta name="citation_volume" content="88"><meta name="citation_firstpage" content="540"><meta name="citation_doi" content="10.1038/clpt.2010.142"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3091944/?report=abstract"><meta name="citation_pmid" content="20703222"><meta name="DC.Title" content="Effect of Single-dose Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="A Frymoyer"><meta name="DC.Contributor" content="S Shugarts"><meta name="DC.Contributor" content="M Browne"><meta name="DC.Contributor" content="AHB Wu"><meta name="DC.Contributor" content="L Frassetto"><meta name="DC.Contributor" content="LZ Benet"><meta name="DC.Date" content="2010 Oct"><meta name="DC.Identifier" content="10.1038/clpt.2010.142"><meta name="DC.Language" content="en"><meta property="og:title" content="Effect of Single-dose Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers"><meta property="og:type" content="article"><meta property="og:description" content="Based on in vitro rat and human hepatocyte uptake studies showing inhibition of warfarin uptake in the presence of the non-specific organic anion transporting polypeptide (OATP) inhibitor rifampin, a clinical study was conducted in 10 healthy volunteers. ..."><meta property="og:url" content="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="./PMC3091944_files/pmc.min.css" type="text/css"><link rel="stylesheet" href="./PMC3091944_files/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="./PMC3091944_files/common.min.js">//</script><script type="text/javascript" src="./PMC3091944_files/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:&#39;/pmc/utils/ctxp/&#39;"><script type="text/javascript" src="./PMC3091944_files/jquery.citationexporter.js">//</script><link rel="stylesheet" href="./PMC3091944_files/citationexporter.css" type="text/css"><script type="text/javascript" src="./PMC3091944_files/MathJax.js"></script><script type="text/javascript" src="./PMC3091944_files/large-obj-scrollbars.min.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><link rel="alternate" type="application/epub+zip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/epub/"><link rel="alternate" type="application/pdf" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/pdf/nihms-290843.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="http://www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="F4FC1A7876C27FE100000000005F4592"><link type="text/css" rel="stylesheet" href="./PMC3091944_files/3855312.css"><link type="text/css" rel="stylesheet" href="./PMC3091944_files/3929378.css" media="print"><style type="text/css" media="print">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('http://www.ncbi.nlm.nih.gov/stat?jsevent=print&ncbi_app=pmc&ncbi_db=pmc&ncbi_pcid=%2Farticles%2FPMC3091944%2F&ncbi_pdid=article&ncbi_phid=F4FC1A7876C27FE100000000005F4592'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-jig-5"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="http://www.ncbi.nlm.nih.gov/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="./PMC3091944_files/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a><ul id="resources-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/" tabindex="-1" role="menuitem">All Resources</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#chemicals-bioassays" tabindex="-1" role="menuitem" class="expandRight">Chemicals &amp; Bioassays</a><ul class="actual-resources-submenu chemicals-bioassays ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcassay" title=" Contributed bioactivity data for PubChem Substances " tabindex="-1" role="menuitem">PubChem BioAssay</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pccompound" title=" Unique, standardized chemical structures " tabindex="-1" role="menuitem">PubChem Compound</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcsubstance" title=" Provides information on the biological activities of small molecules. " tabindex="-1" role="menuitem">PubChem Substance</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/" tabindex="-1" role="menuitem">All Chemicals &amp; Bioassays Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#dna-rna" tabindex="-1" role="menuitem" class="expandRight">DNA &amp; RNA</a><ul class="actual-resources-submenu dna-rna ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/" title=" DNA and RNA sequences submitted to NCBI " tabindex="-1" role="menuitem">GenBank</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/" tabindex="-1" role="menuitem">All DNA &amp; RNA Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#data-software" tabindex="-1" role="menuitem" class="expandRight">Data &amp; Software</a><ul class="actual-resources-submenu data-software ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/" tabindex="-1" role="menuitem">All Data &amp; Software Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#domains-structures" tabindex="-1" role="menuitem" class="expandRight">Domains &amp; Structures</a><ul class="actual-resources-submenu domains-structures ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/structure/" title=" Database of 3D macromolecular structures derived from PDB " tabindex="-1" role="menuitem">Structure (Molecular Modeling Database)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/" tabindex="-1" role="menuitem">All Domains &amp; Structures Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#genes-expression" tabindex="-1" role="menuitem" class="expandRight">Genes &amp; Expression</a><ul class="actual-resources-submenu genes-expression ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gene" title=" Database of gene loci and associated transcripts and proteins " tabindex="-1" role="menuitem">Gene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geo/" title=" Gene Expression Omnibus (GEO) Database " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Database </a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gds" title=" Curated collections of gene expression data sets " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Datasets</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geoprofiles/" title=" Database of gene expression Profiles for individual sequences " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Profiles</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/" tabindex="-1" role="menuitem">All Genes &amp; Expression Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#genetics-medicine" tabindex="-1" role="menuitem" class="expandRight">Genetics &amp; Medicine</a><ul class="actual-resources-submenu genetics-medicine ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gtr/" title=" Detailed information about genetic tests and labs " tabindex="-1" role="menuitem">Genetic Testing Registry</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/" tabindex="-1" role="menuitem">All Genetics &amp; Medicine Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#genomes-maps" tabindex="-1" role="menuitem" class="expandRight">Genomes &amp; Maps</a><ul class="actual-resources-submenu genomes-maps ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sites/genome" title=" Curated genomic DNA sequences " tabindex="-1" role="menuitem">Genome</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/bioproject/" title=" Central status pages for genome sequencing projects " tabindex="-1" role="menuitem">Genome Project</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/" tabindex="-1" role="menuitem">All Genomes &amp; Maps Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#homology" tabindex="-1" role="menuitem" class="expandRight">Homology</a><ul class="actual-resources-submenu homology ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/" tabindex="-1" role="menuitem">All Homology Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#literature" tabindex="-1" role="menuitem" class="expandRight">Literature</a><ul class="actual-resources-submenu literature ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nlmcatalog/journals" title=" Information on journals cited by NCBI records " tabindex="-1" role="menuitem">Journals in NCBI Databases</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mesh" title=" Controlled vocabulary for MEDLINE " tabindex="-1" role="menuitem">MeSH Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/" title=" Reviews of clinical effectiveness research " tabindex="-1" role="menuitem">PubMed Health</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/" tabindex="-1" role="menuitem">All Literature Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#proteins" tabindex="-1" role="menuitem" class="expandRight">Proteins</a><ul class="actual-resources-submenu proteins ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/protein" title=" Protein sequence data " tabindex="-1" role="menuitem">Protein Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/" tabindex="-1" role="menuitem">All Proteins Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#sequence-analysis" tabindex="-1" role="menuitem" class="expandRight">Sequence Analysis</a><ul class="actual-resources-submenu sequence-analysis ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/" tabindex="-1" role="menuitem">All Sequence Analysis Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#taxonomy" tabindex="-1" role="menuitem" class="expandRight">Taxonomy</a><ul class="actual-resources-submenu taxonomy ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/taxonomy" title=" The NCBI taxonomy tree in Entrez " tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Root" title=" Displays and links Entrez data to each taxonomic node " tabindex="-1" role="menuitem">Taxonomy Browser</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/wwwcmt.cgi" title=" Creates custom taxonomic trees " tabindex="-1" role="menuitem">Taxonomy Common Tree</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/" tabindex="-1" role="menuitem">All Taxonomy Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#training-tutorials" tabindex="-1" role="menuitem" class="expandRight">Training &amp; Tutorials</a><ul class="actual-resources-submenu training-tutorials ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/education/" title=" Central page providing links to tutorials and training materials " tabindex="-1" role="menuitem">NCBI Education Page</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/" tabindex="-1" role="menuitem">All Training &amp; Tutorials Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#variation" tabindex="-1" role="menuitem" class="expandRight">Variation</a><ul class="actual-resources-submenu variation ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/snp" title=" Database of nucleotide sequence polymorphisms " tabindex="-1" role="menuitem">Database of Single Nucleotide Polymorphisms (dbSNP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/" tabindex="-1" role="menuitem">All Variation Resources...</a></li></ul></li></ul></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a><ul id="howto-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/#howtos" tabindex="-1" role="menuitem">All How To</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/#howtos" tabindex="-1" role="menuitem">Chemicals &amp; Bioassays</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/#howtos" tabindex="-1" role="menuitem">DNA &amp; RNA</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/#howtos" tabindex="-1" role="menuitem">Data &amp; Software</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/#howtos" tabindex="-1" role="menuitem">Domains &amp; Structures</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/#howtos" tabindex="-1" role="menuitem">Genes &amp; Expression</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/#howtos" tabindex="-1" role="menuitem">Genetics &amp; Medicine</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/#howtos" tabindex="-1" role="menuitem">Genomes &amp; Maps</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/#howtos" tabindex="-1" role="menuitem">Homology</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/#howtos" tabindex="-1" role="menuitem">Literature</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/#howtos" tabindex="-1" role="menuitem">Proteins</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/#howtos" tabindex="-1" role="menuitem">Sequence Analysis</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/#howtos" tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/#howtos" tabindex="-1" role="menuitem">Training &amp; Tutorials</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/#howtos" tabindex="-1" role="menuitem">Variation</a></li></ul></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="http://www.ncbi.nlm.nih.gov/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="http://www.ncbi.nlm.nih.gov/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3091944%2F" id="sign_in">Sign in to NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/signout/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3091944%2F" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="http://www.ncbi.nlm.nih.gov/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="http://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="http://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="http://www.ncbi.nlm.nih.gov/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbook">ToolKitBook</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" config="dictionary:&#39;pmc-search-autocomplete&#39;,disableUrl:&#39;NcbiSearchBarAutoComplCtrl&#39;" autocomplete="off" data-sbconfig="ds:&#39;no&#39;,pjs:&#39;no&#39;,afs:&#39;yes&#39;" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" style="visibility: hidden;"><img src="./PMC3091944_files/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/limits/">Limits</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="http://www.ncbi.nlm.nih.gov/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="http://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="http://www.ncbi.nlm.nih.gov/pmc/?term=hhs%20author%20manuscript[filter]&amp;cmd=search&amp;EntrezSystem2.PEntrez.Pmc.Pmc_LimitsTab.LimitsOff=true" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3091944</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="./PMC3091944_files/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="http://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="http://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="http://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="http://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [&#39;h2&#39;], headingExclude: &#39;:hidden&#39;" id="ui-jig-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div>Clin Pharmacol Ther. Author manuscript; available in PMC 2011 May 10.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20703222" target="pmc_ext" ref="reftype=publisher&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal"><span class="cit">Clin Pharmacol Ther. 2010 Oct; 88(4): 540–547. </span></a></div><span class="fm-vol-iss-date">Published online 2010 Aug 11. </span> <span class="doi">doi:&nbsp; <a href="http://dx.doi.org/10.1038%2Fclpt.2010.142" target="pmc_ext" ref="reftype=other&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1038/clpt.2010.142</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3091944</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS290843</span></div></div></div></div></div><h1 class="content-title">Effect of Single-dose Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Frymoyer%20A%5Bauth%5D">A Frymoyer</a>,<sup>1,</sup><sup>2</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Shugarts%20S%5Bauth%5D">S Shugarts</a>,<sup>2</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Browne%20M%5Bauth%5D">M Browne</a>,<sup>2</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Wu%20A%5Bauth%5D">AHB Wu</a>,<sup>3</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Frassetto%20L%5Bauth%5D">L Frassetto</a>,<sup>4</sup> and  <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Benet%20L%5Bauth%5D">LZ Benet</a><sup>1,</sup><sup>2</sup></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="id241126_ai" style="display:none"><div class="fm-affl" lang="en"><sup>1</sup>Division of Clinical Pharmacology, University of California, San Francisco</div><div class="fm-affl" lang="en"><sup>2</sup>Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco</div><div class="fm-affl" lang="en"><sup>3</sup>Department of Laboratory Medicine, University of California, San Francisco</div><div class="fm-affl" lang="en"><sup>4</sup>Department of Medicine, University of California, San Francisco</div><div id="CR1">Correspondence: Leslie Z. Benet, PhD, Department of Bioengineering and Therapeutic Sciences, Box 0912, Schools of Pharmacy and Medicine, University of California, San Francisco, San Francisco, CA 94143-0446. <span class="before-email-separator"></span><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fscu@teneB.eilseL" class="oemail">ude.fscu@teneB.eilseL</a>; Tel: 415-476-3853; Fax: 415-476-8887</div></div><div class="togglers"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" class="pmctoggle" rid="id241126_ai">Author information <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" class="pmctoggle" rid="id241126_cpl">Copyright and License information <span>►</span></a></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="id241126_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright notice</a>  and <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Disclaimer</a></div></div></div><div class="links-box fm-panel whole_rhythm"><div class="small"><div>The publisher's final edited version of this article is available  at <a href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20703222" target="pmc_ext" ref="reftype=publisher&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal">Clin Pharmacol Ther</a></div><div>See other articles in PMC that <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="__abstractid818501" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-7"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true" id="ui-jig-8">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__abstractid818501title">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">Based on <em>in vitro</em> rat and human hepatocyte uptake studies showing inhibition of warfarin uptake in the presence of the non-specific organic anion transporting polypeptide (OATP) inhibitor rifampin, a clinical study was conducted in 10 healthy volunteers. In a randomized, single-dose, two-period, crossover design, subjects received a 7.5 mg dose of warfarin alone or immediately following a 600 mg intravenous dose of rifampin. Rifampin did not significantly alter R- or S- warfarin area under the concentration-time curve (AUC) from 0–12 hours (period of hepatic OATP inhibition by rifampin) or C<sub>max</sub> (maximum plasma concentration). AUC<sub>0–∞</sub> was decreased on rifampin days for both R- (25% reduction; p &lt; 0.001) and S-warfarin (15% reduction; p &lt; 0.05). No differences were seen on the area under the INR-time curve. Our study suggests hepatic uptake via OATPs may not be clinically important in the pharmacokinetics of warfarin.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">warfarin, pharmacokinetics, drug transporters, drug interaction, healthy volunteers</span></div></div><div id="S1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-9"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-10">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">INTRODUCTION</h2><p id="P2" class="p p-first">Warfarin is a commonly prescribed anticoagulant for the prevention of venous thromboembolism, systemic embolism, and other thromboembolic events. But, successful use of warfarin has been challenged by its large inter-individual variation in required warfarin dose and narrow therapeutic index.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519692" role="button" aria-expanded="false" aria-haspopup="true">1</a>) Doses can differ &gt;10-fold among patients to achieve similar levels of anticoagulation. In attempts to explain the variability in warfarin dose, formal pharmacogenetic techniques have been applied to try and identify potential common genetic polymorphisms in genes that may be important. It is now well-recognized that Single Nucleotide Polymorphisms (SNPs) in warfarin's major metabolizing enzyme (cytochrome P-450 (CYP) 2C9) and its pharmacodynamic target (vitamin K epoxide reductase; VKORC1) have a significant impact on warfarin dose requirement.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519717" role="button" aria-expanded="false" aria-haspopup="true">2</a>–<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519720" role="button" aria-expanded="false" aria-haspopup="true">5</a>) Multiple investigators have incorporated patients' genetic status within these genes along with demographic factors (i.e. age, weight, gender, ethnicity, interacting drugs, etc.) into dosing algorithms for improved dose prediction.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519695" role="button" aria-expanded="false" aria-haspopup="true">6</a>–<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519698" role="button" aria-expanded="false" aria-haspopup="true">9</a>) Yet, these regression models can only account for at most 55–60% of the variability in warfarin dose.</p><p id="P3">The Biopharmaceutics Drug Disposition Classification System (BDDCS), which classifies drugs based on the characteristics of solubility and extent of metabolism, allows investigators to predict whether intestinal and hepatic transporters can potentially affect disposition of a drug.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519681" role="button" aria-expanded="false" aria-haspopup="true">10</a>) Specifically, BDDCS predicts that following oral dosing of poorly soluble, extensively metabolized drugs (i.e. Class 2 drugs), efflux transporter effects may predominate in the intestine, but both uptake and efflux transporter effects can be important in the liver. In those organs where the relevant metabolizing enzymes are located, extensive transporter-enzyme interplay will also occur. Recent human pharmacokinetic studies from our laboratory have demonstrated <em>in vivo</em> the importance of hepatic uptake via organic anion transporting polypeptides (OATPs) in the disposition of two BDDCS Class 2 drugs: atorvastatin(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519685" role="button" aria-expanded="false" aria-haspopup="true">11</a>) and glyburide.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519718" role="button" aria-expanded="false" aria-haspopup="true">12</a>) Using concomitant administration of single dose intravenous rifampin as a non-specific OATP inhibitor, hepatic uptake inhibition resulted in a 1.3 and 6.8 fold increase in glyburide and atorvastin exposure, respectively, as measured by the total area under the concentration-time curve (AUC). The importance of uptake transporters has been shown for a number of other Class 2 drugs as well.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519700" role="button" aria-expanded="false" aria-haspopup="true">13</a>)</p><p id="P4">Warfarin is a racemic mixture of S- and R- enatiomers with S-warfarin being 2–5 times more potent and conferring the majority of its anticoagulant activity.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R14" rid="R14" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">14</a>) Both the S- and R-enatiomers are eliminated almost exclusively by CYP metabolism, i.e., S-warfarin principally by CYP2C9 metabolism to form the primary metabolite 7-hydroxywarfarin (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R14" rid="R14" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">14</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519683" role="button" aria-expanded="false" aria-haspopup="true">15</a>); R-warfarin principally by CYP3A4 metabolism to form 10-hydroxywarfarin.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519702" role="button" aria-expanded="false" aria-haspopup="true">15</a>)</p><p id="P5" class="p p-last">Since warfarin is classified as a BDDCS Class 2 drug(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519678" role="button" aria-expanded="false" aria-haspopup="true">10</a>), the potential for hepatic uptake transporters to play a role in its pharmacokinetics should be considered, a proposition not previously studied. By inhibiting the uptake of warfarin into the liver, warfarin would have decreased access to its major metabolizing CYP enzymes resulting in an increased AUC. Based on initial <em>in vitro</em> rat and human hepatocyte data showing decreased uptake of warfarin in the presence of rifampin, a clinical trial in healthy volunteers was conducted to examine the impact of hepatic uptake inhibition on warfarin pharmacokinetics.</p></div><div id="S2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-11"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-12">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S2title">RESULTS</h2><div id="S3" class="sec sec-first"><h3>In Vitro Study – Rat and Human Hepatocyte Uptake</h3><p id="P6" class="p p-first-last">In the presence of 100 μM rifampin, the uptake of 1 μM racemic warfarin was decreased by 23% in rat hepatocytes (p &lt; 0.05; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F1/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1A</span></a>) and 34% in human hepatocytes (p&lt; 0.001; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F1/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>) compared to control.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><img src="./PMC3091944_files/nihms-290843-f0001.gif" class="small-thumb" alt="Figure 1" title="Figure 1" src-large="/pmc/articles/PMC3091944/bin/nihms-290843-f0001.jpg"></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a4--><div><span>Inhibition of the uptake of warfarin (1μM) by rifampin (100 μM) into (a) rat and (b) human hepatocytes. Values are mean ± SD (rat, n = 9 per group; human, n = 6 per group). * p&lt;0.05; ** p &lt; 0.001 compared to control.</span> <strong>...</strong></div></div></div></div><div id="S4" class="sec sec-last"><h3>Clinical Study</h3><div id="S5" class="sec sec-first"><p></p><h4 class="inline">Pharmacokinetics of S- and R-warfarin </h4><p id="P7" class="p p-first"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a> displays the concentration-time profiles of S- and R-warfarin after a single oral dose of 7.5 mg warfarin alone or with a single intravenous dose of rifampin. Data from a previous study by our laboratory and information provided in the package insert, predict relevant concentrations of rifampin for up to 12 hours after a single 600 mg intravenous dose(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519712" role="button" aria-expanded="false" aria-haspopup="true">11</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R16" rid="R16" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>). Therefore, in the current study we focused on S- and R-warfarin concentration-time data from 0–12 hours (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a> <em>inset</em>) that would represent the time period of hepatic OATP inhibition by rifampin and when any uptake effects on warfarin pharmacokinetics, if any, would be seen. Rifampin had no effect on the AUC<sub>0–12h</sub> of S-warfarin or R-warfarin compared to control days when warfarin was given alone (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T1/" target="true" class="fig-table-link table figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>), as well as C<sub>max</sub> (maximum plasma concentration) and T<sub>max</sub> (time of maximum concentration).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><img src="./PMC3091944_files/nihms-290843-f0002.gif" class="small-thumb" alt="Figure 2" title="Figure 2" src-large="/pmc/articles/PMC3091944/bin/nihms-290843-f0002.jpg"></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a4--><div><span>The effect of a single dose of intravenous rifampin on the mean plasma concentrations of (a) S-warfarin and (b) R-warfarin in 10 healthy volunteers after a single oral dose of 7.5 mg racemic warfarin. <em>Inset:</em> depicts 0 to 12 h data only. Error bars show</span> <strong>...</strong></div></div></div><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T1"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T1/" target="table" rid-ob="ob-T1" rid-figpopup="T1" class="table img_link icnblk_img figpopup"><img alt="Table 1" title="Table 1" class="small-thumb" src="./PMC3091944_files/saved_resource" src-large="/pmc/articles/PMC3091944/table/T1/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T1/" target="table" rid-figpopup="T1" rid-ob="ob-T1">Table 1</a></div><!--caption a4--><div><span>Pharmacokinetic parameters<sup><sup>a</sup></sup> of R- and S-warfarin in 10 healthy volunteers following a single oral dose of 7.5 mg warfarin alone or in combination with a single dose of intravenous rifampin.</span></div></div></div><p id="P8" class="p p-last">Analysis of all concentration-time data showed rifampin significantly decreased the AUC<sub>0–∞</sub> of S-warfarin by 15% (p &lt; 0.04) and R-warfarin by 25% (p &lt; 0.001) (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T1/" target="true" class="fig-table-link table figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). The apparent terminal half-life (t<sub>1/2</sub>) of S-warfarin was not significantly different on rifampin days (p = 0.13). For R-warfarin, a 25% shortening of the terminal t<sub>1/2</sub> was seen on rifampin days (p &lt; 0.001). The steady-state volume of distribution (V<sub>ss</sub>/F) was unaffected by the presence of rifampin for both S- and R-warfarin.</p></div><div id="S6" class="sec"><p></p><h4 class="inline">Pharmacokinetics of warfarin metabolites </h4><p id="P9" class="p p-first-last">The concentration-time profiles of 7-hydroxywarfarin (S-warfarin metabolite) and 10-hydroxywarfarin (R-warfarin metabolite) after a single oral dose of 7.5 mg warfarin alone or with a single intravenous dose of rifampin are shown in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F3/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>. Rifampin had no significant effect on 7-hydroxywarfarin AUC<sub>0–12h</sub> or any other its pharmacokinetic parameters (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T2/" target="true" class="fig-table-link table figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). For 10-hydroxywarfarin, rifampin also had no effect on the AUC<sub>0–12h</sub>(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T2/" target="true" class="fig-table-link table figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). But, after 12 hours the concentration-time profile of 10-hydroxywarfarin between treatments began to diverge with higher concentrations on rifampin days (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F3/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3b</span></a>). The C<sub>max</sub> of 10-hydroxywarfarin was increased 111% on rifampin days (p &lt; 0.001) but no change in T<sub>max</sub> was seen. Rifampin treatment also resulted in an 84% increase in the AUC<sub>0–120h</sub> (p &lt; 0.001) and 16% increase in the AUC<sub>0–∞</sub> (p &lt; 0.05) of 10-hydroxywarfarin. Terminal t<sub>1/2</sub> decreased 50% on rifampin days (p &lt; 0.001). Because of its extremely long terminal t<sub>1/2</sub>, a large portion of 10-hydroxywarfarin's concentration-time profile was not captured within our sampling time-period (0–120 hour), and therefore, a significant proportion of AUC<sub>0–∞</sub> was extrapolated (warfarin alone, 64 +/− 11%; warfarin plus rifampin, 44% +/− 12%,). For the same reason, our terminal t<sub>1/2</sub> estimate for 10-hydroxywarfarin may not exclusively represent the terminal phase.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><img src="./PMC3091944_files/nihms-290843-f0003.gif" class="small-thumb" alt="Figure 3" title="Figure 3" src-large="/pmc/articles/PMC3091944/bin/nihms-290843-f0003.jpg"></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a4--><div><span>The effect of a single dose of intravenous rifampin on the mean plasma concentrations of (a) 7-hydroxywarfarin and (b) 10-hydroxywarfarin in 10 healthy volunteers after a single oral dose of 7.5 mg racemic warfarin. <em>Inset:</em> depicts the same data on a semilogarithmic</span> <strong>...</strong></div></div></div><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T2"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T2/" target="table" rid-ob="ob-T2" rid-figpopup="T2" class="table img_link icnblk_img figpopup"><img alt="Table 2" title="Table 2" class="small-thumb" src="./PMC3091944_files/saved_resource(1)" src-large="/pmc/articles/PMC3091944/table/T2/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T2/" target="table" rid-figpopup="T2" rid-ob="ob-T2">Table 2</a></div><!--caption a4--><div><span>Pharmacokinetic parameters<sup><sup>a</sup></sup> of warfarin metabolites in 10 healthy volunteers following a single oral dose of 7.5 mg warfarin alone or in combination with a single dose of intravenous rifampin.</span></div></div></div></div><div id="S7" class="sec"><p></p><h4 class="inline">AUC ratios of metabolite to parent </h4><p id="P10" class="p p-first-last">The AUC<sub>0–∞</sub> ratio of 7-hydroxywarfarin to S-warfarin and 10-hydroxywarfarin to R-warfarin increased 20% and 58% respectively with rifampin treatment (p &lt; 0.01 for both; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T3/" target="true" class="fig-table-link table figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>).</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T3"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T3/" target="table" rid-ob="ob-T3" rid-figpopup="T3" class="table img_link icnblk_img figpopup"><img alt="Table 3" title="Table 3" class="small-thumb" src="./PMC3091944_files/saved_resource(2)" src-large="/pmc/articles/PMC3091944/table/T3/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T3/" target="table" rid-figpopup="T3" rid-ob="ob-T3">Table 3</a></div><!--caption a4--><div><span>AUC<sub>0–∞</sub> ratios of wafarin metabolite to parent during each treatment period.</span></div></div></div></div><div id="S8" class="sec"><p></p><h4 class="inline">Pharmacodynamics </h4><p id="P11" class="p p-first-last">A single 7.5 mg dose of oral warfarin caused a small, transient increase in INR from baseline during each treatment period as reflected in the maximum INR (INR<sub>max</sub>) vs. baseline INR (INR<sub>baseline</sub>; p &lt; 0.01 for both), but rifampin caused no differences in INR measures compared to warfarin alone (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T4/" target="true" class="fig-table-link table figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>).</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T4"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T4/" target="table" rid-ob="ob-T4" rid-figpopup="T4" class="table img_link icnblk_img figpopup"><img alt="Table 4" title="Table 4" class="small-thumb" src="./PMC3091944_files/saved_resource(3)" src-large="/pmc/articles/PMC3091944/table/T4/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T4/" target="table" rid-figpopup="T4" rid-ob="ob-T4">Table 4</a></div><!--caption a4--><div><span>Mean pharmacodynamic parameters in 10 healthy volunteers following a single oral dose of 7.5 mg warfarin alone or in combination with a single dose of intravenous rifampin.</span></div></div></div></div><div id="S9" class="sec sec-last"><p></p><h4 class="inline">Safety </h4><p id="P12" class="p p-first-last">All 10 subjects who were enrolled completed the study. No significant adverse events were observed and no bleeding complications occurred.</p></div></div></div><div id="S10" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-13"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-14">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S10title">DISCUSSION</h2><p id="P13" class="p p-first">In this study, we attempted to determine the importance of hepatic uptake transporters for the disposition of the widely-used, narrow therapeutic index, anticoagulant warfarin. The results of our clinical study demonstrated that co-administration of the potent OATP inhibitor rifampin, given as a single intravenous dose, had no effect on the AUC<sub>0–12h</sub> and C<sub>max</sub> values of S- and R- warfarin or S-warfarin's hydroxyl metabolite. Accordingly, OATP uptake transport is likely not clinically significant for the disposition of warfarin and will provide no further insight into mechanisms of warfarin drug-drug interactions or genetic variation important in warfarin dose selection.</p><p id="P14">Rifampin was chosen as a model OATP inhibitor to block the <em>in vivo</em> OATP-mediated hepatic uptake of warfarin(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519709" role="button" aria-expanded="false" aria-haspopup="true">11</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519694" role="button" aria-expanded="false" aria-haspopup="true">17</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519677" role="button" aria-expanded="false" aria-haspopup="true">18</a>). Because of rifampin's shorter t<sub>1/2</sub> (2.9 ±0.9 h(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519707" role="button" aria-expanded="false" aria-haspopup="true">19</a>)) relative to S- and R- warfarin (39h and 49h respectively, as determined in our clinical study) and because we could not give rifampin as multiple doses dues to its metabolic enzyme induction effect, rifampin was only present in plasma for a portion of warfarin's concentration-time curve.OATP inhibition and any potential effect on warfarin pharmacokinetics occurred at most during the time of rifampin presence, and therefore, outcome measures for our study needed to be suitably selected to capture this period of OATP inhibition. Previous reports have shown that after a single 600 mg intravenous dose of rifampin to healthy volunteers, rifampin was present for up to 12–24 hours in plasma. (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519713" role="button" aria-expanded="false" aria-haspopup="true">11</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R16" rid="R16" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>) Assuming a similar time of exposure for rifampin in our clinical study, the best parameters to capture the potential effects of OATP inhibition on warfarin pharmacokinetics were the AUC<sub>0–12h</sub> and C<sub>max</sub>. No effect on either of these pharmacokinetic parameters for S- or R-warfarin were seen in the presence of rifampin suggesting OATP transport of warfarin is not clinically important.</p><p id="P15">Two previous clinical studies by our laboratory using a similar study design as used here demonstrated significant changes in the pharmacokinetics of atorvastatin and glyburide with hepatic OATP inhibition by rifampin(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519716" role="button" aria-expanded="false" aria-haspopup="true">11</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519687" role="button" aria-expanded="false" aria-haspopup="true">12</a>). The AUC of atorvastatin was 680% higher and the AUC of glyburide 130% higher in rifampin vs. control phases. In those clinical studies rifampin also produced a large decrease in the V<sub>ss</sub>/F for both drugs (atorvastatin, 93% decrease; glyburide, 60% decrease). This decrease in V<sub>ss</sub>/F likely demonstrated inhibition of uptake transporter mechanisms important for drug distribution in tissues. In our current study we did not see a change in V<sub>ss</sub>/F for S- or R-warfarin on rifampin days (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T1/" target="true" class="fig-table-link table figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>), which we would have predicted if OATP transport processes were important for warfarin distribution.</p><p id="P16">In contrast to our clinical study, our <em>in vitro</em> data showed that warfarin uptake into hepatocytes was inhibited by rifampin in both rats and humans (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/figure/F1/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>) presumably via OATP uptake transporter inhibition. The magnitude of warfarin uptake inhibition (23% in rat hepatocytes and 34% in human hepatocytes) was modest at the concentration of rifampin (100 μM) used for the hepatocyte uptake studies. The 100 μM concentration of rifampin used in our hepatocyte uptake studies is significantly higher than peak plasma concentrations that were likely achieved in our healthy volunteers after a single IV dose of 600 mg rifampin (17–20μM (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519703" role="button" aria-expanded="false" aria-haspopup="true">11</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R16" rid="R16" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>)) and could explain the disagreement between our <em>in vitro</em> and <em>in vivo</em> results, but the <em>in vitro</em> effects were similar to what we observed <em>in vitro</em> with glyburide. We cannot rule-out the possibility that higher plasma concentrations of rifampin would result in additional OATP inhibition and therefore alter warfarin pharmcokinetics, although the clinical relevance would be questionable. The discordance between our <em>in vitro</em> and <em>in vivo</em> data highlights the importance of translational research in drug transporter research and the need to verify the clinical relevance of all preclinical findings using appropriately designed clinical trials.</p><p id="P17">Our healthy volunteer clinical data are in line with the numerous genome wide association studies (GWAS) undertaken to identify polymorphisms in the human genome that may be important in warfarin dose selection. In these GWAS studies, no common variants in hepatic uptake transporters or any other drug transporters were found to be significant in determining the warfarin dose requirements of patients.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519686" role="button" aria-expanded="false" aria-haspopup="true">2</a>–<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519679" role="button" aria-expanded="false" aria-haspopup="true">5</a>) Genetic variants of a transporter will not produce a significant signal in a GWAS if the drug is not a substrate for the transporter of interest since changes in transporter function will not alter the drug's pharmacokinetics and thus dose requirements. This negative predictive value has now been demonstrated nicely for warfarin and OATP uptake transporters through the results of our clinical study and the above mentioned GWASs. In contrast, for drugs that are known substrates of uptake or efflux transporters including OTAP1B1 and OATP1B3, established polymorphisms in the corresponding transporter have been shown to alter drug pharmacokinetics in human clinical studies.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519691" role="button" aria-expanded="false" aria-haspopup="true">13</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519714" role="button" aria-expanded="false" aria-haspopup="true">20</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519708" role="button" aria-expanded="false" aria-haspopup="true">21</a>)</p><p id="P18">Intravenous administration of rifampin conceivably minimized any potential confounding interactions in the intestine at either the enzyme or transporter level although the lack of an interaction cannot be fully confirmed. By giving rifampin as a single dose, we attempted to avoid the well-described and clinically relevant CYP induction effect seen with multiple dosing.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R16" rid="R16" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519705" role="button" aria-expanded="false" aria-haspopup="true">22</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519684" role="button" aria-expanded="false" aria-haspopup="true">23</a>) Induction of both CYP2C9(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519701" role="button" aria-expanded="false" aria-haspopup="true">24</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519675" role="button" aria-expanded="false" aria-haspopup="true">25</a>) and CYP3A4 (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519719" role="button" aria-expanded="false" aria-haspopup="true">25</a>–<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519696" role="button" aria-expanded="false" aria-haspopup="true">28</a>), the major metabolizing enzymes for S- and R-warfarin respectively, has been described after multiple dose rifampin. The effect of multiple dose rifampin on warfarin pharmacokinetics was highlighted in a clinical trial of four healthy men.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519697" role="button" aria-expanded="false" aria-haspopup="true">24</a>) After 3 days of pretreatment with 300 mg oral rifampin twice per day, a three-fold increase in R-warfarin clearance and a two-fold increase in S-warfarin clearance were seen. Interestingly, our clinical study using only single dose rifampin immediately prior to warfarin likely demonstrates a mild enzyme inductive effect indicated by the small but significant decrease in AUC<sub>0–∞</sub> for S- and R-warfarin (15% decrease and 25% decrease respectively) and terminal t<sub>1/2</sub> for R-warfarin (25% decrease) with rifampin treatment. The increase in C<sub>max</sub> and AUC for the R-warfarin metabolite 10-hydroxywarfarin and the increase in the AUC ratio of 10-hydroxywarfarin to R-warfarin further supports induction of R-warfarin metabolism via CYP3A4. The pharmacokinetics of the specific S-warfarin metabolite 7-hydroxywarfarin did not change with rifampin treatment and therefore is not congruent with induction of S-warfarin metabolism via CYP2C9.</p><p id="P19">The pharmacokinetic effect of enzyme induction appeared to be delayed since early in the time course S- and R-warfarin concentration-time curves, AUC<sub>0–12h</sub>, and C<sub>max</sub> were similar with and without rifampin. Such a delay is expected based on the mechanism of rifampin enzyme induction through activation of the nuclear transcription factor pregnane X receptor (PXR).(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519680" role="button" aria-expanded="false" aria-haspopup="true">23</a>) A previous clinical study examining the time-course of CYP enzyme induction with multiple-dose rifampin using verapamil as a probe substrate reported a half-life of 1 day for the increase in CYP enzyme activity.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519711" role="button" aria-expanded="false" aria-haspopup="true">29</a>) CYP induction after single dose rifampin has previously been shown with a single dose of 1200 mg oral rifampin given 12 hours before oral nifedipine, resulting in a 64% decrease in the AUC<sub>0–∞</sub> of nifedipine.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519673" role="button" aria-expanded="false" aria-haspopup="true">30</a>) Nonetheless, the potential induction of warfarin metabolism by single-dose rifampin in our study does not alter the interpretation of the primary objective of this study as any induction was small (especially for the more biologically active S-warfarin) and it occurred late in the time-course after the primary endpoints (0–12 hours).</p><p id="P20">We purposely selected a warfarin dose for this study (7.5mg) that would provide adequate drug levels for pharmacokinetic analysis, yet in favor of subject safety produce minimal anticoagulation. Our nominal increase in anticoagulation was similar to a previous healthy volunteer study that also used a single 7.5mg dose of oral warfarin.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519693" role="button" aria-expanded="false" aria-haspopup="true">31</a>) The addition of rifampin had no effect on the warfarin pharmacodynamic response as measured by INR<sub>max</sub> and AUC<sub>0–96h, INR</sub> (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/table/T3/" target="true" class="fig-table-link table figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>) and is in general agreement with our pharmacokinetic data. However, the study was neither designed nor powered to detect a difference in pharmacodynamics.</p><p id="P21" class="p p-last">In conclusion, our single dose clinical study of the effect of rifampin on warfarin pharmacokinetics in healthy volunteers suggeststhat hepatic uptake via OATP may not be clinicallyimportant in the disposition for this highly metabolized, narrow therapeutic index, anticoagulant. Single-dose rifampin may induce metabolizing enzymes such as CYP2C9 and CYP3A4.</p></div><div id="S11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-15"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-16">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S11title">METHODS</h2><div id="S12" class="sec sec-first"><h3>In Vitro Study</h3><div id="S13" class="sec sec-first-last"><p></p><h4 class="inline">Hepatocyte Uptake Studies </h4><p id="P22" class="p p-first">Rat hepatocytes were isolated from Male Sprague-Dawley rats (250–300g, Charles River Laboratories, Wilmington, MA) as previously described by our laboratory(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519674" role="button" aria-expanded="false" aria-haspopup="true">32</a>) and suspended in oxygenated hepatocyte wash buffer with 1% bovine serum albumin to yield a concentration of 1 million cells/ml. Cryopreserved human hepatocytes pooled from 5 female and 5 male donors were used according to the provider's instructions (CellzDirect™; Durham, NC). In brief, hepatocytes were thawed quickly in a 37°C water bath and washed twice with ice-cold hepatocyte wash buffer to remove cryopreservation solution. Cells were suspended in oxygenated hepatocyte wash buffer to yield a concentration of 0.5 million cells/mL.</p><p id="P23" class="p p-last">Suspended hepatocytes were then pre-incubated for 5 minute in a 37°C water bath with either control (0.1% DMSO) or 100 μM rifampin. The 100 μM concentration of rifampin was chosen to maximize OATP inhibition and any effect on warfarin uptake Rifampin is a known inhibitor of the 3 major human OATPs, being a more potent inhibitor of OATP1B1 and OATP1B3 than OATP2B1.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519682" role="button" aria-expanded="false" aria-haspopup="true">18</a>,<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519699" role="button" aria-expanded="false" aria-haspopup="true">33</a>) The uptake study was initiated by addition of 1 μM racemic warfarin (Sigma-Aldrich; St. Louis, MO). After 2 minutes of uptake, a 0.5 mL aliquot was transferred to a tube containing 700 μL of silicone:mineral oil mixture (83.3:16.7 v/v). The tube was then centrifuged for 10 sec at 13,000 rpm to isolate the hepatocyte pellet. The oil mixture was removed and the pellet was lysed by sonication in the presence of 200 μL H<sub>2</sub>O. The samples were then prepared for HPLC-MS/MS analysis by liquid-liquid extraction. Student's <em>t-</em>test was used to analyze differences between the two groups (rat, n = 9 per group; human, n =6 per group).</p></div></div><div id="S14" class="sec sec-last"><h3>Clinical Study</h3><div id="S15" class="sec sec-first"><p></p><h4 class="inline">Subjects </h4><p id="P24" class="p p-first-last">Subjects were 6 male and 4 female paid, non-smoking, healthy volunteers 23 to 55 years of age (mean age 30 ± 10 years). Their mean BMI was 25.6 ± 3.5 kg/m<sup>2</sup>. Participants included four Caucasians, four Asians/Pacific Islanders and two Hispanics/Latinos. After written informed consent was obtained, subjects underwent a screening visit consisting of a medical history, physical examination, and standard clinical laboratory tests (general hematology, blood chemistry, coagulation studies, urinalysis, and urine pregnancy) to confirm eligibility. In addition, CYP2C9 genotyping was performed and only subjects who were CYP2C9 *1/*1 were included. All subjects were medication free throughout study enrollment. The study was approved by the Committee on Human Research of the University of California, San Francisco.</p></div><div id="S16" class="sec"><p></p><h4 class="inline">Study design </h4><p id="P25" class="p p-first">A randomized, open-labeled, single-dose, two-period, crossover clinical pharmacokinetic study was conducted at the Clinical Research Center at the University of California, San Francisco. The study followed the protocol used previously in our laboratory to document the importance of OATP hepatic uptake in healthy voluneteers for atorvastatin(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519715" role="button" aria-expanded="false" aria-haspopup="true">11</a>) and glyburide(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519690" role="button" aria-expanded="false" aria-haspopup="true">12</a>). Subjects received on Day 1 of each study period either (A) 7.5 mg warfarin (one 7.5 mg warfarin tab; Bristol-Myers Squibb, Princeton, NJ) or (B) 7.5 mg warfarin immediately following a 30-minute intravenous infusion of 600 mg rifampin (600 mg rifampin powder for injection reconstituted in 10 ml sterile water; Bedford Laboratories, Bedford, OH). Each subject received both treatments separated by a minimum of 14 days, and the treatment order was determined by randomization. Subjects fasted starting the night before until 3 hours after a warfarin dose, abstained from caffeinated beverages, alcoholic beverages and orange juice starting the night before until 24 hours after a warfarin dose. Grapefruit and grapefruit juice were not allowed to be consumed from 7 days before the first study day until completion of the entire study.</p><p id="P26" class="p p-last">Venous blood samples (8ml) for drug level measurements were collected at the following times relative to warfarin dosing: predose, 1, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, 120 hours. The blood samples were centrifuged within 30 minutes, and plasma was separated and stored at −80°C until analysis. In addition, venous blood samples (5ml) were collected for INR determination at 0, 12, 24, 48, 72 and 96 hours after warfarin dosing.</p></div><div id="S17" class="sec"><p></p><h4 class="inline">Pharmacokinetic analysis </h4><p id="P27" class="p p-first">Pharmacokinetic parameters for R- and S-warfarin and their major metabolites were estimated from plasma concentration data via non-compartmental analysis using WinNonlin Professional software (version 5.2.1; Pharsight Corporation, Mountain View, CA). The C<sub>max</sub> and corresponding T<sub>max</sub> were obtained directly from the observed data. The terminal rate constant (λ<sub>z</sub>) was determined by linear regression analysis of the terminal portion of the log plasma concentration–time curve. We were most interested in rifampin's inhibitory effect on hepatic OATPs and the anticipated changes in R- and S-warfarin pharmacokinetics (i.e. AUC). Given S-warfarin's much longer half-life(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519672" role="button" aria-expanded="false" aria-haspopup="true">31</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519689" role="button" aria-expanded="false" aria-haspopup="true">34</a>–<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519706" role="button" aria-expanded="false" aria-haspopup="true">41</a>) compared to rifampin(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519704" role="button" aria-expanded="false" aria-haspopup="true">41</a>), rifampin was expected to be present in plasma for only portion of warfarin's concentration time profile. Data from a previous study by our laboratory and information provided in the package insert, predict relevant plasma concentrations of rifampin for up to 12 hours after a single 600 mg intravenous dose.(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519710" role="button" aria-expanded="false" aria-haspopup="true">11</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R16" rid="R16" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>) Accordingly, our primary outcome was the AUC<sub>0–12h</sub> of S- and R-warfarin, which represents the time a potential inhibitory effect on hepatic OATPs by rifampin would occur.</p><p id="P28" class="p p-last">AUC<sub>0–12h</sub> and AUC<sub>0–120h</sub> were found using the linear/logarithmic trapezoidal method. Summation of AUC<sub>0–120h</sub> and the concentration at the last measured point divided by λ<sub>z</sub> yielded AUC<sub>0–∞</sub>. The terminal half-life (t<sub>1/2</sub>) was calculated as ln 2/λ<sub>z</sub>. CL/F was calculated as dose/AUC<sub>0–∞</sub>. The mean residence time (MRT) was calculated as the ratio of the area under the first moment curve (AUMC<sub>0–∞</sub>) divided by AUC<sub>0–∞</sub> minus the estimated mean absorption time (MAT) (i.e., MRT=(AUMC<sub>0–∞</sub> / AUC<sub>0–∞</sub>) − MAT). MAT was the reciprocal of the first-order absorption rate (k<sub>a</sub>) constant estimated when fitting warfarin data to a two-compartmental model with first-order absorption. V<sub>ss</sub>/F was calculated as MRT × CL/F. The values of CL/F and Vss/F were normalized by body weight.</p></div><div id="S18" class="sec"><p></p><h4 class="inline">Pharmacodynamic analysis </h4><p id="P29" class="p p-first-last">Pharmacodynamic parameters were estimated from the INR data on each treatment day by non-compartmental methods using WinNonlin. Baseline INR (INR<sub>baseline</sub>) and maximum INR (INR<sub>max</sub>) were obtained directly from the observed data. Area under the INR-time curve from 0 to 96 hours (AUC<sub>0–96h, INR</sub>) was calculated using the linear/logarithmic trapezoidal method.</p></div><div id="S19" class="sec"><p></p><h4 class="inline">Statistical analysis </h4><p id="P30" class="p p-first-last">Using previously reported warfarin pharmacokinetic data in healthy volunteers(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519688" role="button" aria-expanded="false" aria-haspopup="true">31</a>), a sample size of 10 subjects would provide &gt; 80% power to detect a 30% difference in S-warfarin AUC<sub>0–∞</sub> between the two treatments. Logarithmic transformation of C<sub>max</sub>, t<sub>1/2</sub>, V<sub>ss</sub>/F, CL/F, AUC<sub>0–12h</sub>, AUC<sub>0–∞</sub> was performed prior to statistical analysis. Pharmacokinetic and pharmacodynamic parameters were compared between the two treatments by use of the paired t-test, except for T<sub>max</sub> in which the Wilcoxon's signed rank test was used. Data are presented as mean ± standard deviation. In addition, the geometric mean ratios of the rifampin treatment values relative to control values (warfarin alone) and their 95% confidence intervals were calculated for all parameters. The data were analyzed using STATA 10 (StataCorp LP, College Station, TX). Differences were considered statistically significant at p &lt; 0.05.</p></div><div id="S20" class="sec sec-last"><p></p><h4 class="inline">Analytic Methods </h4><p id="P31" class="p p-first">The concentrations of S- and R-warfarin and their main metabolites were measured using high pressure liquid chromatography/tandem mass spectrometry system consisting of an Applied Biosystems AB4000 triple quadrupole mass spectrometer (Foster City, CA) with electrospray negative ionization mode. The multiple reaction monitor was set at 307–161 <em>m/z</em> for R- and S-warfarin, 323–177 <em>m/z</em> for 7-hydroxy-warfarin, 323–250 <em>m/z</em> for 10-hydroxy-warfarin, 312–166 <em>m/z</em> for d<sub>5</sub>-warfarin (internal standard for S- and R-warfarin) and 312–117 <em>m/z</em> for d<sub>5</sub>-warfarin (internal standard for metabolites).</p><p id="P32">The samples and standards for S- and R-warfarin (Sigma-Aldrich, St. Louis, MO) were prepared by liquid-liquid extraction of 0.5 mL plasma with 2.5 mL methyl t-butyl ether containing 1μM d<sub>5</sub>-warfarin as internal standard. After being vortexed for one minute, the sample was centrifuged at 3,000 rpm for 10 min. The bottom aqueous layer was frozen via a dry-ice/methanol bath. The top organic layer was collected, dried under nitrogen, and then reconstituted in acetonitrile for analysis.</p><p id="P33">The samples and standards for warfarin metabolites were prepared by liquid-liquid extraction of 100μL plasma with 500μL of methanol containing 1μM d<sub>5</sub>-warfarin as internal standard. Samples were vortexed for one minute followed by centrifugation at 13,000 rpm for 10 min. The supernatant was collected and dried under nitrogen. The residue was reconstituted in 50:50 methanol:H<sub>2</sub>O then centrifuged at 13,000 rpm for 5 min. The supernatant was collected for analysis.</p><p id="P34">Chromatographic conditions for S- and R-warfarin were as described by Naidong and colleagues(<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_219519676" role="button" aria-expanded="false" aria-haspopup="true">43</a>). In brief, R-warfarin and S-warfarin were separated isocratically on a Cyclobond™ I 2000 β-cyclodextrin 250 × 4.6mm, 5μm column with a Cyclobond™ I 2000 50 × 4.6, 5μm guard column (Sigma-Aldrich, St. Louis, MO). R-d<sub>5</sub>-warfarin and S-d<sub>5</sub>-warfarin (racemic d<sub>5</sub>-warfarin from Toronto Research Chemicals, Inc., Ontario, Canada) enantiomers were also separated by the β-cyclodextrin column and co-eluted with R-warfarin and S-warfarin, respectively. The mobile phase consisted of acetonitrile:acetic acid:triethylamine (1000:3:2.5 v:v:v) and the flow rate was 1mL/min. The injection volume was 100μL. Retention times were 7.5 min for S-warfarin and 8.3 min for R-warfarin.</p><p id="P35">Chromatography for warfarin metabolites was performed on an Agilent Eclipse XDB C18 column (150 × 4.6 mm, 5μm particle size, Agilent Technologies, Santa Clara, CA). The mobile phase A was 0.1% acetic acid in H<sub>2</sub>O and mobile phase B was 0.1% acetic acid in methanol. The mobile phase gradient was as follows: 0–0.5 min 50% B; 5.5 min 90% B; 5.6–9.0 min 100% B, 9.5–10.0 min 50% B at a flow rate of 1mL/min. The run time was 10 min.</p><p id="P36" class="p p-last">The methods for S- and R-warfarin were validated from 1.5 to 300 ng/ml. The 1 h and 2 h samples were diluted 1-fold to ensure concentrations within the validated range. The methods for 7-hydroxywarfarin and 10-hydroxywarfarin were validated from 1.5 to 150 ng/ml. The curves were linear over the validated ranges and 1/x<sup>2</sup> weighting was used.</p></div></div></div><div id="S21" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-17"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-18">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S21title">ACKNOWLEDGEMENTS</h2><div class="sec"><p id="__p1">This study was supported in part by NIH grants GM61390 and GM75900. It was carried out in part in the Clinical Research Center, Moffitt Hospital, University of California, San Francisco, which is supported by the National Institutes of Health (NIH) / National Center for Research Resources (NCRR) UCSF-CTSI Grant Number UL1 RR024131. A.F. is supported by Grant T32 GM07546 from the National Institute of General Medical Sciences. S.S. was supported during a portion of these studies as an Amgen fellow. The authors thank the nurses and staff at the Clinical Research Center, Moffitt Hospital, University of California, San Francisco for their help with the clinical study and Andrew Smith for his help with subject genotyping. This work was presented at the 2010 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting, March 17, Atlanta, GA by AF as an ASCPT Presidential Trainee Award Winner.</p></div></div><div id="__fn-groupid226270" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-19"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-20">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__fn-groupid226270title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"></p><p id="P37" class="p p-first-last"><strong>DISCLOSURE</strong> The authors have no conflict of interests to declare.</p><p></p></div></div><div id="__ref-listid1182554" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-21"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-22">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ref-listid1182554title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">(1) <span class="element-citation">Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. <span><span class="ref-journal">Chest. </span>2004;<span class="ref-vol">126</span>:204S–233S.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15383473" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">(2) <span class="element-citation">Caldwell MD, et al.  CYP4F2 genetic variant alters required warfarin dose. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">111</span>:4106–4112.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2288721/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18250228" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">(3) <span class="element-citation">Cooper GM, et al.  A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">112</span>:1022–1027.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515139/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18535201" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">(4) <span class="element-citation">Takeuchi F, et al.  A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>:e1000433.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652833/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19300499" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">(5) <span class="element-citation">Wadelius M, et al.  Association of warfarin dose with genes involved in its action and metabolism. <span><span class="ref-journal">Hum. Genet. </span>2007;<span class="ref-vol">121</span>:23–34.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797064/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17048007" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">(6) <span class="element-citation">Gage BF, et al.  Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>2008;<span class="ref-vol">84</span>:326–331.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683977/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18305455" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">(7) <span class="element-citation">Wadelius M, et al.  The largest prospective warfarin-treated cohort supports genetic forecasting. <span><span class="ref-journal">Blood. </span>2009;<span class="ref-vol">113</span>:784–792.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630264/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18574025" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">(8) <span class="element-citation">Wu AH, et al.  Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations. <span><span class="ref-journal">Pharmacogenomics. </span>2008;<span class="ref-vol">9</span>:169–178.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18370846" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">(9) <span class="element-citation">Schelleman H, et al.  Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>2008;<span class="ref-vol">84</span>:332–339.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538606/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18596683" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">(10) <span class="element-citation">Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. <span><span class="ref-journal">Pharm. Res. </span>2005;<span class="ref-vol">22</span>:11–23.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15771225" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">(11) <span class="element-citation">Lau YY, Huang Y, Frassetto L, Benet LZ. Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>2007;<span class="ref-vol">81</span>:194–204.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17192770" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">(12) <span class="element-citation">Zheng HX, Huang Y, Frassetto LA, Benet LZ. Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>2009;<span class="ref-vol">85</span>:78–85.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582657/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18843263" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">(13) <span class="element-citation">Shugarts S, Benet LZ. The role of transporters in the pharmacokinetics of orally administered drugs. <span><span class="ref-journal">Pharm. Res. </span>2009;<span class="ref-vol">26</span>:2039–2054.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719753/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19568696" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">(14) <span class="element-citation"><span class="ref-journal">Coumadin(R) Tablets.</span> Bristol-Meyers Squibb Company; Princeton, NJ: 2007.  package insert.</span></div><div class="ref-cit-blk half_rhythm" id="R15">(15) <span class="element-citation">Kaminsky LS, Zhang ZY. Human P450 metabolism of warfarin. <span><span class="ref-journal">Pharmacol. Ther. </span>1997;<span class="ref-vol">73</span>:67–74.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9014207" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">(16) <span class="element-citation"><span class="ref-journal">Rifampin for injection USP.</span> Bedford Laboratories; Bedford, OH: 2004.  package insert.</span></div><div class="ref-cit-blk half_rhythm" id="R17">(17) <span class="element-citation">Baldes C, Koenig P, Neumann D, Lenhof HP, Kohlbacher O, Lehr CM. Development of a fluorescence-based assay for screening of modulators of human organic anion transporter 1B3 (OATP1B3) <span><span class="ref-journal">Eur. J. Pharm. Biopharm. </span>2006;<span class="ref-vol">62</span>:39–43.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16129589" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">(18) <span class="element-citation">Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. <span><span class="ref-journal">Hepatology. </span>2002;<span class="ref-vol">36</span>:164–172.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12085361" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">(19) <span class="element-citation">Israili ZH, Rogers CM, el-Attar H. Pharmacokinetics of antituberculosis drugs in patients. <span><span class="ref-journal">J. Clin. Pharmacol. </span>1987;<span class="ref-vol">27</span>:78–83.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/3680559" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">(20) <span class="element-citation">Niemi M. Role of OATP transporters in the disposition of drugs. <span><span class="ref-journal">Pharmacogenomics. </span>2007;<span class="ref-vol">8</span>:787–802.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18240907" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">(21) <span class="element-citation">Zair ZM, Eloranta JJ, Stieger B, Kullak-Ublick GA. Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney. <span><span class="ref-journal">Pharmacogenomics. </span>2008;<span class="ref-vol">9</span>:597–624.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18466105" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">(22) <span class="element-citation">Finch CK, Chrisman CR, Baciewicz AM, Self TH. Rifampin and rifabutin drug interactions: an update. <span><span class="ref-journal">Arch. Intern. Med. </span>2002;<span class="ref-vol">162</span>:985–992.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11996607" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">(23) <span class="element-citation">Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivisto KT. Pharmacokinetic interactions with rifampicin: clinical relevance. <span><span class="ref-journal">Clin. Pharmacokinet. </span>2003;<span class="ref-vol">42</span>:819–850.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12882588" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">(24) <span class="element-citation">Heimark LD, Gibaldi M, Trager WF, O'Reilly RA, Goulart DA. The mechanism of the warfarin-rifampin drug interaction in humans. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>1987;<span class="ref-vol">42</span>:388–394.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/3665337" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">(25) <span class="element-citation">Kanebratt KP, et al.  Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>2008;<span class="ref-vol">84</span>:589–594.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18650803" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">(26) <span class="element-citation">Backman JT, Kivisto KT, Olkkola KT, Neuvonen PJ. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin. <span><span class="ref-journal">Eur. J. Clin. Pharmacol. </span>1998;<span class="ref-vol">54</span>:53–58.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9591931" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">(27) <span class="element-citation">Bidstrup TB, Stilling N, Damkier P, Scharling B, Thomsen MS, Brosen K. Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide. <span><span class="ref-journal">Eur. J. Clin. Pharmacol. </span>2004;<span class="ref-vol">60</span>:109–114.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15034704" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">(28) <span class="element-citation">Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ. Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects. <span><span class="ref-journal">Br. J. Clin. Pharmacol. </span>2004;<span class="ref-vol">57</span>:181–187.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884432/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14748817" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">(29) <span class="element-citation">Fromm MF, Busse D, Kroemer HK, Eichelbaum M. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. <span><span class="ref-journal">Hepatology. </span>1996;<span class="ref-vol">24</span>:796–801.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8855178" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">(30) <span class="element-citation">Ndanusa BU, Mustapha A, Abdu-Aguye I. The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine. <span><span class="ref-journal">J. Pharm. Biomed. Anal. </span>1997;<span class="ref-vol">15</span>:1571–1575.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9226591" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">(31) <span class="element-citation">Washington C, Hou SY, Hughes NC, Campanella C, Berner B. Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics. <span><span class="ref-journal">J. Clin. Pharmacol. </span>2007;<span class="ref-vol">47</span>:1320–1326.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17724088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">(32) <span class="element-citation">Lam JL, Okochi H, Huang Y, Benet LZ. In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay. <span><span class="ref-journal">Drug Metab. Dispos. </span>2006;<span class="ref-vol">34</span>:1336–1344.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16698890" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">(33) <span class="element-citation">Treiber A, Schneiter R, Häusler S, Stieger B. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. <span><span class="ref-journal">Drug Metab Dispos. </span>2007;<span class="ref-vol">35</span>:1400–1407.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17496208" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">(34) <span class="element-citation">Jiang X, et al.  Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. <span><span class="ref-journal">Br. J. Clin. Pharmacol. </span>2004;<span class="ref-vol">57</span>:592–599.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884493/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15089812" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">(35) <span class="element-citation">Jiang X, et al.  Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. <span><span class="ref-journal">Br. J. Clin. Pharmacol. </span>2005;<span class="ref-vol">59</span>:425–432.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884814/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15801937" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">(36) <span class="element-citation">Kim JS, Nafziger AN, Gaedigk A, Dickmann LJ, Rettie AE, Bertino JS., Jr. Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe. <span><span class="ref-journal">J. Clin. Pharmacol. </span>2001;<span class="ref-vol">41</span>:715–722.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11452703" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">(37) <span class="element-citation">Kong AN, et al.  Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin. <span><span class="ref-journal">J. Clin. Pharmacol. </span>1995;<span class="ref-vol">35</span>:1008–1015.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8568008" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">(38) <span class="element-citation">Lilja JJ, Backman JT, Neuvonen PJ. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. <span><span class="ref-journal">Clin. Pharmacol. Ther. </span>2007;<span class="ref-vol">81</span>:833–839.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17392729" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">(39) <span class="element-citation">Mohammed Abdul MI, et al.  Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. <span><span class="ref-journal">Br. J. Pharmacol. </span>2008;<span class="ref-vol">154</span>:1691–1700.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518459/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18516070" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">(40) <span class="element-citation">Soon D, et al.  Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men. <span><span class="ref-journal">J. Clin. Pharmacol. </span>2006;<span class="ref-vol">46</span>:1179–1187.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16988207" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">(41) <span class="element-citation">Uno T, Sugimoto K, Sugawara K, Tateishi T. The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers. <span><span class="ref-journal">J. Clin. Pharm. Ther. </span>2008;<span class="ref-vol">33</span>:67–73.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18211619" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">(42) <span class="element-citation">Loos U, Musch E, Jensen JC, Mikus G, Schwabe HK, Eichelbaum M. Pharmacokinetics of oral and intravenous rifampicin during chronic administration. <span><span class="ref-journal">Klin. Wochenschr. </span>1985;<span class="ref-vol">63</span>:1205–11.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/4087830" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">(43) <span class="element-citation">Naidong W, Ring PR, Midtlien C, Jiang X. Development and validation of a sensitive and robust LC-tandem MS method for the analysis of warfarin enantiomers in human plasma. <span><span class="ref-journal">J. Pharm. Biomed. Anal. </span>2001;<span class="ref-vol">25</span>:219–26.</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11275431" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#__abstractid818501title">Abstract</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#S1title">INTRODUCTION</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#S2title">RESULTS</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#S10title">DISCUSSION</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#S11title">METHODS</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#S21title">ACKNOWLEDGEMENTS</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#__fn-groupid226270title">Footnotes</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#__ref-listid1182554title">REFERENCES</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="try-button"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/?report=reader"><img src="./PMC3091944_files/3838809" alt="PubReader format: click here to try"></a></div><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/epub/">ePub (beta)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/pdf/nihms-290843.pdf">PDF (355K)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" data-citationid="PMC3091944" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3091944%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3091944_files/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3091944%2F&amp;text=Effect%20of%20Single-dose%20Rifampin%20on%20the%20Pharmacokinetics%20of%20Warfarin%20in%20Healthy%20Volunteers" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3091944_files/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3091944%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3091944_files/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="20703222" data-aiid="3091944" data-aid="3091944" data-iid="196463" data-domainid="319" data-domain="nihpa" data-accid="PMC3091944" data-md5="45bbd86f384482746bf866a90000d9f2">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-39" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-39" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input type="hidden" name="absid" id="absid" value="3091944"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="http://www.ncbi.nlm.nih.gov/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:&#39;#favUL&#39;,starExists:true,createCollectionUrl:&#39;#&#39;,manageCollectionsUrl:&#39;/myncbi/collections/&#39;"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="http://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input type="submit" class="button_apply" name="addtocollection" value="1"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-41" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-41" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/21496065" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Effects of fesoterodine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.</a><span class="source">[Br J Clin Pharmacol. 2011]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-43" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malhotra B, Alvey C, Gong J, Li X, Duczynski G, Gandelman K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Br J Clin Pharmacol. 2011 Aug; 72(2):257-62. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/18679669" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.</a><span class="source">[Eur J Clin Pharmacol. 2008]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-45" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Almeida L, Falcão A, Vaz-da-Silva M, Nunes T, Santos AT, Rocha JF, Neta C, Macedo T, Fontes-Ribeiro C, Soares-da-Silva P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Clin Pharmacol. 2008 Oct; 64(10):961-6. Epub 2008 Aug 6.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/16624870" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.</a><span class="source">[Drug Metab Dispos. 2006]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-47" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lau YY, Okochi H, Huang Y, Benet LZ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drug Metab Dispos. 2006 Jul; 34(7):1175-81. Epub 2006 Apr 19.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/19067473" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.</a><span class="source">[Clin Drug Investig. 2009]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-49" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vakily M, Lee RD, Wu J, Gunawardhana L, Mulford D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Drug Investig. 2009; 29(1):35-50. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/23614393" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarin.</a><span class="source">[Epilepsia. 2013]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-51" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stockis A, van Lier JJ, Cawello W, Kumke T, Eckhardt K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Epilepsia. 2013 Jul; 54(7):1161-6. Epub 2013 Apr 24.</em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20703222&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20703222&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-53" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-53" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691435/" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective</a><span class="source">[The AAPS Journal. 2013]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-55" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Prueksaritanont T, Chu X, Gibson C, Cui D, Yee KL, Ballard J, Cabalu T, Hochman J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">The AAPS Journal. 2013 Mar 30; 15(3)629-645</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684558/" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">The Role of BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in Drug Development</a><span class="source">[Journal of pharmaceutical scie...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-57" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Benet LZ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Journal of pharmaceutical sciences. 2012 Nov 12; 102(1)34-42</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394135/" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects</a><span class="source">[British Journal of Clinical Ph...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-59" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Krishna R, Stypinski D, Ali M, Garg A, Cote J, Maes A, DeGroot B, Liu Y, Li S, Connolly SM, Wagner JA, Stoch SA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">British Journal of Clinical Pharmacology. 2012 Jan 13; 74(1)116-124</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231854/" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">BDDCS Applied to Over 900 Drugs</a><span class="source">[The AAPS Journal. 2011]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-61" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Benet LZ, Broccatelli F, Oprea TI. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">The AAPS Journal. 2011 Aug 5; 13(4)519-547</em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/citedby/" ref="reftype=relart&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-63" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-63" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=3091944" ref="reftype=Compound&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-65" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3091944" ref="reftype=MedGen&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-67" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/20703222/" ref="reftype=PubMed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-69" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=3091944" ref="reftype=Substance&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-71" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-73" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-73" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState(&#39;ClearHT&#39;)">Clear</a><a href="javascript:historyDisplayState(&#39;HTOff&#39;)" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState(&#39;HTOn&#39;)" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2876f2911de5257dada7">Effect of Single-dose Rifampin on the Pharmacokinetics of Warfarin in Healthy Vo...</a><div class="ralinkpop offscreen_noflow">Effect of Single-dose Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2010 Oct; 88(4)540</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=2" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c28747fd84438f0ea1ebe">PMC3091944 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c281bf2911de5257d9e76">Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its ...</a><div class="ralinkpop offscreen_noflow">Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2010 Oct; 88(4)499</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=4" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2818f0c03b7981758e9c">PMC3056523 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c280304fcfad59176c25b">Potential impact of cytochrome P450 3A5 in human liver on drug interactions with...</a><div class="ralinkpop offscreen_noflow">Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles<div class="brieflinkpopdesc">British Journal of Clinical Pharmacology. 2010 Jun; 69(6)593</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState(&#39;HTOn&#39;)">Turn recording back on</a></p>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--P2" name="crb--P2" rid="P2" style="position: absolute; visibility: visible; width: 370px; top: 829px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-75"><ul>
<li class="two_line" reference_id="R1">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15383473/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.</a><span class="one_line_source">[Chest.  2004]</span><div class="alt-note">
<div class="authors">Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E</div>
<div class="citation">Chest. 2004 Sep; 126(3 Suppl):204S-233S.</div>
</div>
</li>
<li class="two_line" reference_id="R2">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18250228/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">CYP4F2 genetic variant alters required warfarin dose.</a><span class="one_line_source">[Blood.  2008]</span><div class="alt-note">
<div class="authors">Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, Hubbard J, Turpaz Y, Langaee TY, Eby C, King CR, Brower A, Schmelzer JR, Glurich I, Vidaillet HJ, Yale SH, Qi Zhang K, Berg RL, Burmester JK</div>
<div class="citation">Blood. 2008 Apr 15; 111(8):4106-12.</div>
</div>
</li>
<li class="two_line" reference_id="R5">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17048007/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association of warfarin dose with genes involved in its action and metabolism.</a><span class="one_line_source">[Hum Genet.  2007]</span><div class="alt-note">
<div class="authors">Wadelius M, Chen LY, Eriksson N, Bumpstead S, Ghori J, Wadelius C, Bentley D, McGinnis R, Deloukas P</div>
<div class="citation">Hum Genet. 2007 Mar; 121(1):23-34.</div>
</div>
</li>
<li class="two_line" reference_id="R6">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18305455/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL</div>
<div class="citation">Clin Pharmacol Ther. 2008 Sep; 84(3):326-31.</div>
</div>
</li>
<li class="two_line" reference_id="R9">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18596683/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Schelleman H, Chen J, Chen Z, Christie J, Newcomb CW, Brensinger CM, Price M, Whitehead AS, Kealey C, Thorn CF, Samaha FF, Kimmel SE</div>
<div class="citation">Clin Pharmacol Ther. 2008 Sep; 84(3):332-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P3" name="crb--P3" rid="P3" style="position: absolute; visibility: visible; width: 370px; top: 1092px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-76"><ul>
<li class="two_line" reference_id="R10">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15771225/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.</a><span class="one_line_source">[Pharm Res.  2005]</span><div class="alt-note">
<div class="authors">Wu CY, Benet LZ</div>
<div class="citation">Pharm Res. 2005 Jan; 22(1):11-23.</div>
</div>
</li>
<li class="two_line" reference_id="R11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17192770/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.</a><span class="one_line_source">[Clin Pharmacol Ther.  2007]</span><div class="alt-note">
<div class="authors">Lau YY, Huang Y, Frassetto L, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2007 Feb; 81(2):194-204.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18843263/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.</a><span class="one_line_source">[Clin Pharmacol Ther.  2009]</span><div class="alt-note">
<div class="authors">Zheng HX, Huang Y, Frassetto LA, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2009 Jan; 85(1):78-85.</div>
</div>
</li>
<li class="two_line" reference_id="R13">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19568696/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The role of transporters in the pharmacokinetics of orally administered drugs.</a><span class="one_line_source">[Pharm Res.  2009]</span><div class="alt-note">
<div class="authors">Shugarts S, Benet LZ</div>
<div class="citation">Pharm Res. 2009 Sep; 26(9):2039-54.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P4" name="crb--P4" rid="P4" style="position: absolute; visibility: visible; width: 370px; top: 1376px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-77"><ul><li class="two_line" reference_id="R15">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9014207/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Human P450 metabolism of warfarin.</a><span class="one_line_source">[Pharmacol Ther.  1997]</span><div class="alt-note">
<div class="authors">Kaminsky LS, Zhang ZY</div>
<div class="citation">Pharmacol Ther. 1997; 73(1):67-74.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P5" name="crb--P5" rid="P5" style="position: absolute; visibility: visible; width: 370px; top: 1492px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-78"><ul><li class="two_line" reference_id="R10">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15771225/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.</a><span class="one_line_source">[Pharm Res.  2005]</span><div class="alt-note">
<div class="authors">Wu CY, Benet LZ</div>
<div class="citation">Pharm Res. 2005 Jan; 22(1):11-23.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P7" name="crb--P7" rid="P7" style="position: absolute; visibility: visible; width: 370px; top: 2003px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-79"><ul><li class="two_line" reference_id="R11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17192770/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.</a><span class="one_line_source">[Clin Pharmacol Ther.  2007]</span><div class="alt-note">
<div class="authors">Lau YY, Huang Y, Frassetto L, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2007 Feb; 81(2):194-204.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P14" name="crb--P14" rid="P14" style="position: absolute; visibility: visible; width: 370px; top: 3877px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-80"><ul>
<li class="two_line" reference_id="R11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17192770/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.</a><span class="one_line_source">[Clin Pharmacol Ther.  2007]</span><div class="alt-note">
<div class="authors">Lau YY, Huang Y, Frassetto L, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2007 Feb; 81(2):194-204.</div>
</div>
</li>
<li class="two_line" reference_id="R17">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16129589/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Development of a fluorescence-based assay for screening of modulators of human organic anion transporter 1B3 (OATP1B3).</a><span class="one_line_source">[Eur J Pharm Biopharm.  2006]</span><div class="alt-note">
<div class="authors">Baldes C, Koenig P, Neumann D, Lenhof HP, Kohlbacher O, Lehr CM</div>
<div class="citation">Eur J Pharm Biopharm. 2006 Jan; 62(1):39-43.</div>
</div>
</li>
<li class="two_line" reference_id="R18">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12085361/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.</a><span class="one_line_source">[Hepatology.  2002]</span><div class="alt-note">
<div class="authors">Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K</div>
<div class="citation">Hepatology. 2002 Jul; 36(1):164-72.</div>
</div>
</li>
<li class="two_line" reference_id="R19">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/3680559/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetics of antituberculosis drugs in patients.</a><span class="one_line_source">[J Clin Pharmacol.  1987]</span><div class="alt-note">
<div class="authors">Israili ZH, Rogers CM, el-Attar H</div>
<div class="citation">J Clin Pharmacol. 1987 Jan; 27(1):78-83.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P15" name="crb--P15" rid="P15" style="position: absolute; visibility: visible; width: 370px; top: 4165px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-81"><ul>
<li class="two_line" reference_id="R11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17192770/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.</a><span class="one_line_source">[Clin Pharmacol Ther.  2007]</span><div class="alt-note">
<div class="authors">Lau YY, Huang Y, Frassetto L, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2007 Feb; 81(2):194-204.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18843263/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.</a><span class="one_line_source">[Clin Pharmacol Ther.  2009]</span><div class="alt-note">
<div class="authors">Zheng HX, Huang Y, Frassetto LA, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2009 Jan; 85(1):78-85.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P16" name="crb--P16" rid="P16" style="position: absolute; visibility: visible; width: 370px; top: 4350px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-82"><ul><li class="two_line" reference_id="R11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17192770/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.</a><span class="one_line_source">[Clin Pharmacol Ther.  2007]</span><div class="alt-note">
<div class="authors">Lau YY, Huang Y, Frassetto L, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2007 Feb; 81(2):194-204.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P17" name="crb--P17" rid="P17" style="position: absolute; visibility: visible; width: 370px; top: 4634px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-83"><ul>
<li class="two_line" reference_id="R2">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18250228/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">CYP4F2 genetic variant alters required warfarin dose.</a><span class="one_line_source">[Blood.  2008]</span><div class="alt-note">
<div class="authors">Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, Hubbard J, Turpaz Y, Langaee TY, Eby C, King CR, Brower A, Schmelzer JR, Glurich I, Vidaillet HJ, Yale SH, Qi Zhang K, Berg RL, Burmester JK</div>
<div class="citation">Blood. 2008 Apr 15; 111(8):4106-12.</div>
</div>
</li>
<li class="two_line" reference_id="R5">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17048007/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association of warfarin dose with genes involved in its action and metabolism.</a><span class="one_line_source">[Hum Genet.  2007]</span><div class="alt-note">
<div class="authors">Wadelius M, Chen LY, Eriksson N, Bumpstead S, Ghori J, Wadelius C, Bentley D, McGinnis R, Deloukas P</div>
<div class="citation">Hum Genet. 2007 Mar; 121(1):23-34.</div>
</div>
</li>
<li class="two_line" reference_id="R13">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19568696/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The role of transporters in the pharmacokinetics of orally administered drugs.</a><span class="one_line_source">[Pharm Res.  2009]</span><div class="alt-note">
<div class="authors">Shugarts S, Benet LZ</div>
<div class="citation">Pharm Res. 2009 Sep; 26(9):2039-54.</div>
</div>
</li>
<li class="two_line" reference_id="R20">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18240907/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Role of OATP transporters in the disposition of drugs.</a><span class="one_line_source">[Pharmacogenomics.  2007]</span><div class="alt-note">
<div class="authors">Niemi M</div>
<div class="citation">Pharmacogenomics. 2007 Jul; 8(7):787-802.</div>
</div>
</li>
<li class="two_line" reference_id="R21">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18466105/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.</a><span class="one_line_source">[Pharmacogenomics.  2008]</span><div class="alt-note">
<div class="authors">Zaïr ZM, Eloranta JJ, Stieger B, Kullak-Ublick GA</div>
<div class="citation">Pharmacogenomics. 2008 May; 9(5):597-624.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P18" name="crb--P18" rid="P18" style="position: absolute; visibility: visible; width: 370px; top: 4876px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-84"><ul>
<li class="two_line" reference_id="R22">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/11996607/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Rifampin and rifabutin drug interactions: an update.</a><span class="one_line_source">[Arch Intern Med.  2002]</span><div class="alt-note">
<div class="authors">Finch CK, Chrisman CR, Baciewicz AM, Self TH</div>
<div class="citation">Arch Intern Med. 2002 May 13; 162(9):985-92.</div>
</div>
</li>
<li class="two_line" reference_id="R23">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12882588/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetic interactions with rifampicin : clinical relevance.</a><span class="one_line_source">[Clin Pharmacokinet.  2003]</span><div class="alt-note">
<div class="authors">Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivistö KT</div>
<div class="citation">Clin Pharmacokinet. 2003; 42(9):819-50.</div>
</div>
</li>
<li class="two_line" reference_id="R24">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/3665337/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The mechanism of the warfarin-rifampin drug interaction in humans.</a><span class="one_line_source">[Clin Pharmacol Ther.  1987]</span><div class="alt-note">
<div class="authors">Heimark LD, Gibaldi M, Trager WF, O'Reilly RA, Goulart DA</div>
<div class="citation">Clin Pharmacol Ther. 1987 Oct; 42(4):388-94.</div>
</div>
</li>
<li class="two_line" reference_id="R25">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18650803/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol.</a><span class="one_line_source">[Clin Pharmacol Ther.  2008]</span><div class="alt-note">
<div class="authors">Kanebratt KP, Diczfalusy U, Bäckström T, Sparve E, Bredberg E, Böttiger Y, Andersson TB, Bertilsson L</div>
<div class="citation">Clin Pharmacol Ther. 2008 Nov; 84(5):589-94.</div>
</div>
</li>
<li class="two_line" reference_id="R28">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/14748817/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects.</a><span class="one_line_source">[Br J Clin Pharmacol.  2004]</span><div class="alt-note">
<div class="authors">Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ</div>
<div class="citation">Br J Clin Pharmacol. 2004 Feb; 57(2):181-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P19" name="crb--P19" rid="P19" style="position: absolute; visibility: visible; width: 370px; top: 5227px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-85"><ul>
<li class="two_line" reference_id="R23">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12882588/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetic interactions with rifampicin : clinical relevance.</a><span class="one_line_source">[Clin Pharmacokinet.  2003]</span><div class="alt-note">
<div class="authors">Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivistö KT</div>
<div class="citation">Clin Pharmacokinet. 2003; 42(9):819-50.</div>
</div>
</li>
<li class="two_line" reference_id="R29">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8855178/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.</a><span class="one_line_source">[Hepatology.  1996]</span><div class="alt-note">
<div class="authors">Fromm MF, Busse D, Kroemer HK, Eichelbaum M</div>
<div class="citation">Hepatology. 1996 Oct; 24(4):796-801.</div>
</div>
</li>
<li class="two_line" reference_id="R30">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9226591/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine.</a><span class="one_line_source">[J Pharm Biomed Anal.  1997]</span><div class="alt-note">
<div class="authors">Ndanusa BU, Mustapha A, Abdu-Aguye I</div>
<div class="citation">J Pharm Biomed Anal. 1997 Jun; 15(9-10):1571-5.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P20" name="crb--P20" rid="P20" style="position: absolute; visibility: visible; width: 370px; top: 5473px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-86"><ul><li class="two_line" reference_id="R31">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17724088/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.</a><span class="one_line_source">[J Clin Pharmacol.  2007]</span><div class="alt-note">
<div class="authors">Washington C, Hou SY, Hughes NC, Campanella C, Berner B</div>
<div class="citation">J Clin Pharmacol. 2007 Oct; 47(10):1320-6.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P22" name="crb--P22" rid="P22" style="position: absolute; visibility: visible; width: 370px; top: 5802px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-87"><ul><li class="two_line" reference_id="R32">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16698890/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay.</a><span class="one_line_source">[Drug Metab Dispos.  2006]</span><div class="alt-note">
<div class="authors">Lam JL, Okochi H, Huang Y, Benet LZ</div>
<div class="citation">Drug Metab Dispos. 2006 Aug; 34(8):1336-44.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P23" name="crb--P23" rid="P23" style="position: absolute; visibility: visible; width: 370px; top: 5981px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-88"><ul>
<li class="two_line" reference_id="R18">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12085361/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.</a><span class="one_line_source">[Hepatology.  2002]</span><div class="alt-note">
<div class="authors">Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K</div>
<div class="citation">Hepatology. 2002 Jul; 36(1):164-72.</div>
</div>
</li>
<li class="two_line" reference_id="R33">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17496208/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.</a><span class="one_line_source">[Drug Metab Dispos.  2007]</span><div class="alt-note">
<div class="authors">Treiber A, Schneiter R, Häusler S, Stieger B</div>
<div class="citation">Drug Metab Dispos. 2007 Aug; 35(8):1400-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P25" name="crb--P25" rid="P25" style="position: absolute; visibility: visible; width: 370px; top: 6420px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-89"><ul>
<li class="two_line" reference_id="R11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17192770/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.</a><span class="one_line_source">[Clin Pharmacol Ther.  2007]</span><div class="alt-note">
<div class="authors">Lau YY, Huang Y, Frassetto L, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2007 Feb; 81(2):194-204.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18843263/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.</a><span class="one_line_source">[Clin Pharmacol Ther.  2009]</span><div class="alt-note">
<div class="authors">Zheng HX, Huang Y, Frassetto LA, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2009 Jan; 85(1):78-85.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P27" name="crb--P27" rid="P27" style="position: absolute; visibility: visible; width: 370px; top: 6778px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-90"><ul>
<li class="two_line" reference_id="R31">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17724088/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.</a><span class="one_line_source">[J Clin Pharmacol.  2007]</span><div class="alt-note">
<div class="authors">Washington C, Hou SY, Hughes NC, Campanella C, Berner B</div>
<div class="citation">J Clin Pharmacol. 2007 Oct; 47(10):1320-6.</div>
</div>
</li>
<li class="two_line" reference_id="R34">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/15089812/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.</a><span class="one_line_source">[Br J Clin Pharmacol.  2004]</span><div class="alt-note">
<div class="authors">Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ</div>
<div class="citation">Br J Clin Pharmacol. 2004 May; 57(5):592-9.</div>
</div>
</li>
<li class="two_line" reference_id="R41">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18211619/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers.</a><span class="one_line_source">[J Clin Pharm Ther.  2008]</span><div class="alt-note">
<div class="authors">Uno T, Sugimoto K, Sugawara K, Tateishi T</div>
<div class="citation">J Clin Pharm Ther. 2008 Feb; 33(1):67-73.</div>
</div>
</li>
<li class="two_line" reference_id="R11">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17192770/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.</a><span class="one_line_source">[Clin Pharmacol Ther.  2007]</span><div class="alt-note">
<div class="authors">Lau YY, Huang Y, Frassetto L, Benet LZ</div>
<div class="citation">Clin Pharmacol Ther. 2007 Feb; 81(2):194-204.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P30" name="crb--P30" rid="P30" style="position: absolute; visibility: visible; width: 370px; top: 7362px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-91"><ul><li class="two_line" reference_id="R31">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17724088/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.</a><span class="one_line_source">[J Clin Pharmacol.  2007]</span><div class="alt-note">
<div class="authors">Washington C, Hou SY, Hughes NC, Campanella C, Berner B</div>
<div class="citation">J Clin Pharmacol. 2007 Oct; 47(10):1320-6.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P34" name="crb--P34" rid="P34" style="position: absolute; visibility: visible; width: 370px; top: 7947px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-92"><ul><li class="two_line" reference_id="R43">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/11275431/" ref="reftype=pubmed&amp;article-id=3091944&amp;issue-id=196463&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Development and validation of a sensitive and robust LC-tandem MS method for the analysis of warfarin enantiomers in human plasma.</a><span class="one_line_source">[J Pharm Biomed Anal.  2001]</span><div class="alt-note">
<div class="authors">Naidong W, Ring PR, Midtlien C, Jiang X</div>
<div class="citation">J Pharm Biomed Anal. 2001 May; 25(2):219-26.</div>
</div>
</li></ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="./PMC3091944_files/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-R1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.<div class="authors">Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E</div><div class="citation">Chest. 2004 Sep; 126(3 Suppl):204S-233S.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15383473/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R1">Ref list</a>]</p></div><div id="body-link-popper-R2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">CYP4F2 genetic variant alters required warfarin dose.<div class="authors">Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, Hubbard J, Turpaz Y, Langaee TY, Eby C, King CR, Brower A, Schmelzer JR, Glurich I, Vidaillet HJ, Yale SH, Qi Zhang K, Berg RL, Burmester JK</div><div class="citation">Blood. 2008 Apr 15; 111(8):4106-12.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18250228/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R2">Ref list</a>]</p></div><div id="body-link-popper-R5" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Association of warfarin dose with genes involved in its action and metabolism.<div class="authors">Wadelius M, Chen LY, Eriksson N, Bumpstead S, Ghori J, Wadelius C, Bentley D, McGinnis R, Deloukas P</div><div class="citation">Hum Genet. 2007 Mar; 121(1):23-34.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17048007/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R5">Ref list</a>]</p></div><div id="body-link-popper-R6" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.<div class="authors">Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL</div><div class="citation">Clin Pharmacol Ther. 2008 Sep; 84(3):326-31.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18305455/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R6">Ref list</a>]</p></div><div id="body-link-popper-R9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.<div class="authors">Schelleman H, Chen J, Chen Z, Christie J, Newcomb CW, Brensinger CM, Price M, Whitehead AS, Kealey C, Thorn CF, Samaha FF, Kimmel SE</div><div class="citation">Clin Pharmacol Ther. 2008 Sep; 84(3):332-9.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18596683/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R9">Ref list</a>]</p></div><div id="body-link-popper-R10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.<div class="authors">Wu CY, Benet LZ</div><div class="citation">Pharm Res. 2005 Jan; 22(1):11-23.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15771225/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R10">Ref list</a>]</p></div><div id="body-link-popper-R11" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.<div class="authors">Lau YY, Huang Y, Frassetto L, Benet LZ</div><div class="citation">Clin Pharmacol Ther. 2007 Feb; 81(2):194-204.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17192770/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R11">Ref list</a>]</p></div><div id="body-link-popper-R12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.<div class="authors">Zheng HX, Huang Y, Frassetto LA, Benet LZ</div><div class="citation">Clin Pharmacol Ther. 2009 Jan; 85(1):78-85.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18843263/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R12">Ref list</a>]</p></div><div id="body-link-popper-R13" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> The role of transporters in the pharmacokinetics of orally administered drugs.<div class="authors">Shugarts S, Benet LZ</div><div class="citation">Pharm Res. 2009 Sep; 26(9):2039-54.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19568696/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R13">Ref list</a>]</p></div><div id="body-link-popper-R14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">(14) <span class="element-citation"><span class="ref-journal">Coumadin(R) Tablets.</span> Bristol-Meyers Squibb Company; Princeton, NJ: 2007.  package insert.</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R14">Ref list</a>]</div><div id="body-link-popper-R15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Human P450 metabolism of warfarin.<div class="authors">Kaminsky LS, Zhang ZY</div><div class="citation">Pharmacol Ther. 1997; 73(1):67-74.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9014207/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R15">Ref list</a>]</p></div><div id="body-link-popper-R16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">(16) <span class="element-citation"><span class="ref-journal">Rifampin for injection USP.</span> Bedford Laboratories; Bedford, OH: 2004.  package insert.</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R16">Ref list</a>]</div><div id="body-link-popper-R17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Development of a fluorescence-based assay for screening of modulators of human organic anion transporter 1B3 (OATP1B3).<div class="authors">Baldes C, Koenig P, Neumann D, Lenhof HP, Kohlbacher O, Lehr CM</div><div class="citation">Eur J Pharm Biopharm. 2006 Jan; 62(1):39-43.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16129589/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R17">Ref list</a>]</p></div><div id="body-link-popper-R18" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.<div class="authors">Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K</div><div class="citation">Hepatology. 2002 Jul; 36(1):164-72.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12085361/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R18">Ref list</a>]</p></div><div id="body-link-popper-R19" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetics of antituberculosis drugs in patients.<div class="authors">Israili ZH, Rogers CM, el-Attar H</div><div class="citation">J Clin Pharmacol. 1987 Jan; 27(1):78-83.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/3680559/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R19">Ref list</a>]</p></div><div id="body-link-popper-R20" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Role of OATP transporters in the disposition of drugs.<div class="authors">Niemi M</div><div class="citation">Pharmacogenomics. 2007 Jul; 8(7):787-802.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18240907/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R20">Ref list</a>]</p></div><div id="body-link-popper-R21" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney.<div class="authors">Zaïr ZM, Eloranta JJ, Stieger B, Kullak-Ublick GA</div><div class="citation">Pharmacogenomics. 2008 May; 9(5):597-624.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18466105/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R21">Ref list</a>]</p></div><div id="body-link-popper-R22" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Rifampin and rifabutin drug interactions: an update.<div class="authors">Finch CK, Chrisman CR, Baciewicz AM, Self TH</div><div class="citation">Arch Intern Med. 2002 May 13; 162(9):985-92.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11996607/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R22">Ref list</a>]</p></div><div id="body-link-popper-R23" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pharmacokinetic interactions with rifampicin : clinical relevance.<div class="authors">Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivistö KT</div><div class="citation">Clin Pharmacokinet. 2003; 42(9):819-50.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12882588/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R23">Ref list</a>]</p></div><div id="body-link-popper-R24" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The mechanism of the warfarin-rifampin drug interaction in humans.<div class="authors">Heimark LD, Gibaldi M, Trager WF, O'Reilly RA, Goulart DA</div><div class="citation">Clin Pharmacol Ther. 1987 Oct; 42(4):388-94.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/3665337/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R24">Ref list</a>]</p></div><div id="body-link-popper-R25" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol.<div class="authors">Kanebratt KP, Diczfalusy U, Bäckström T, Sparve E, Bredberg E, Böttiger Y, Andersson TB, Bertilsson L</div><div class="citation">Clin Pharmacol Ther. 2008 Nov; 84(5):589-94.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18650803/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R25">Ref list</a>]</p></div><div id="body-link-popper-R28" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects.<div class="authors">Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ</div><div class="citation">Br J Clin Pharmacol. 2004 Feb; 57(2):181-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14748817/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R28">Ref list</a>]</p></div><div id="body-link-popper-R29" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.<div class="authors">Fromm MF, Busse D, Kroemer HK, Eichelbaum M</div><div class="citation">Hepatology. 1996 Oct; 24(4):796-801.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8855178/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R29">Ref list</a>]</p></div><div id="body-link-popper-R30" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The effect of single does of rifampicin on the pharmacokinetics of oral nifedipine.<div class="authors">Ndanusa BU, Mustapha A, Abdu-Aguye I</div><div class="citation">J Pharm Biomed Anal. 1997 Jun; 15(9-10):1571-5.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9226591/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R30">Ref list</a>]</p></div><div id="body-link-popper-R31" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.<div class="authors">Washington C, Hou SY, Hughes NC, Campanella C, Berner B</div><div class="citation">J Clin Pharmacol. 2007 Oct; 47(10):1320-6.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17724088/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R31">Ref list</a>]</p></div><div id="body-link-popper-R32" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay.<div class="authors">Lam JL, Okochi H, Huang Y, Benet LZ</div><div class="citation">Drug Metab Dispos. 2006 Aug; 34(8):1336-44.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16698890/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R32">Ref list</a>]</p></div><div id="body-link-popper-R33" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.<div class="authors">Treiber A, Schneiter R, Häusler S, Stieger B</div><div class="citation">Drug Metab Dispos. 2007 Aug; 35(8):1400-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17496208/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R33">Ref list</a>]</p></div><div id="body-link-popper-R34" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.<div class="authors">Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ</div><div class="citation">Br J Clin Pharmacol. 2004 May; 57(5):592-9.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/15089812/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R34">Ref list</a>]</p></div><div id="body-link-popper-R41" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers.<div class="authors">Uno T, Sugimoto K, Sugawara K, Tateishi T</div><div class="citation">J Clin Pharm Ther. 2008 Feb; 33(1):67-73.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18211619/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R41">Ref list</a>]</p></div><div id="body-link-popper-R43" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Development and validation of a sensitive and robust LC-tandem MS method for the analysis of warfarin enantiomers in human plasma.<div class="authors">Naidong W, Ring PR, Midtlien C, Jiang X</div><div class="citation">J Pharm Biomed Anal. 2001 May; 25(2):219-26.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11275431/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#R43">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <div class="breadcrumbs">You are here: 
            <span id="breadcrumb_text"><a href="http://www.ncbi.nlm.nih.gov/guide/">NCBI</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central (PMC)</a></span></div>
    <a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target="_blank" href="http://www.ncbi.nlm.nih.gov/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.35&amp;Time=2016-06-23T14:20:38-04:00&amp;Host=ptpmc202">Write to the Help Desk</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="./PMC3091944_files/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="http://www.nlm.nih.gov/" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="http://www.nih.gov/" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="http://www.dhhs.gov/" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="http://www.usa.gov/" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            
            <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Copyright</a> | <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html#disclaimer">Disclaimer</a> |
            <a href="http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a> | 
            <a href="http://www.ncbi.nlm.nih.gov/guide/browsers/">Browsers</a> | <a href="http://www.nlm.nih.gov/accessibility.html">Accessibility</a> | <a href="http://www.ncbi.nlm.nih.gov/About/glance/contact_info.html">Contact</a>
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="http://www.ncbi.nlm.nih.gov/">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url"><a href="http://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
        </div>
    </div>
    <script type="text/javascript" src="./PMC3091944_files/InstrumentPageStarterJS.js"> </script>    
    <script type="text/javascript" src="./PMC3091944_files/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div><div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 63.5938px; left: 408.188px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: none;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091944/#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: none;">Turn off</a></div></div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=nihpa&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC3091944/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC7E8376854741_0014SID /projects/PMC/PMCViewer@4.35 ptpmc202 v4.1.r480124 Mon, Sep 28 2015 02:46:19 -->

<script type="text/javascript" src="./PMC3091944_files/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1" style="display: none;"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div><ul class="print-log"><li></li></ul></body></html>